CVS SCHEDULE 13G/A: SEC filing
An institutional holder
Filed with the SEC on · accession 0001193125-26-349359
CVS filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 13, 2026. A report the company filed with the SEC (the US market regulator). The stock moved +0.3% by the first close after the filing.
Summary of the filing
An institutional holder filed an amended Schedule 13G disclosing its passive ownership position in CVS Health Corp. The filing indicates a change in the holder's previously reported beneficial ownership stake.
Key details
How CVS stock reacted
Close before
$94.72
Aug 12, 2026
First close after
+0.29%
$94.99
5 trading days
-1.13%
$93.65
Since filing
-11.48%
$83.85
✦ Ask GOAX AI about this filing — what it means for CVS, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CVS?
Click hereFrequently asked questions
What did CVS file with the SEC on Aug 13, 2026?
CVS filed a SCHEDULE 13G/A (SEC filing). An institutional holder filed an amended Schedule 13G disclosing its passive ownership position in CVS Health Corp. The filing indicates a change in the holder's previously reported beneficial ownership stake.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did CVS stock react to this filing?
CVS closed at $94.72 before the filing and $94.99 on Aug 13, 2026 (+0.29%). Five trading days later: $93.65 (-1.13%).
Other CVS SEC filings
- 8-K · DivestitureNov 4, 2026
- 10-Q · SEC filingNov 4, 2026
- 8-K · SEC filingNov 4, 2026
- 8-K · Board changeAug 17, 2026
- 8-K · SEC filingAug 5, 2026
- 10-Q · Material agreementAug 5, 2026
- 144 · Insider sale plannedMay 22, 2026
- 144 · Insider sale plannedMay 21, 2026
- 8-K · SEC filingMay 18, 2026
- 144 · Insider sale plannedMay 8, 2026
Get alerts when CVS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days